Back

Target attainment of Blood Pressure goals with RAS-blockers plus CCB, according to ESC 2018 and 2021 guidelines. Results from a randomized 12-week open-label comparative study

13 April 2023 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Moderated ePoster 3 Epidemiology, Prognosis, Outcome EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Angelos Liontos

University hospital of Ioannina, Ioannina (Greece)

7 More presentations in this session

Presentation thumbnail
Effects of concurrent exercise training on blood pressure variability and values are blunted in subjects with non-dipping blood pressure nocturnal pattern
Doctor G. Caminiti (Rome, IT)
Abstract Slides
Presentation thumbnail
Medication adherence in relation with physical activity in hypertensive patients : data from a behavioral cardiology unit
Doctor C. Chrysohoou (Athens, GR)
Abstract Slides
Presentation thumbnail
Gamma-glutamyl Transferase and insulin resistance. Various effects of RAS-blockade plus CCB combination: results from a randomized 12-week open-label comparative study
Doctor A. Liontos (Ioannina, GR)
Presentation thumbnail
Indices of renal function alternation with RAS-blockers plus CCB combinations: a randomized 12-week open-label comparative study
Doctor A. Liontos (Ioannina, GR)
Presentation thumbnail
Arterial hypertension management in patients with confirmed coronary heart disease: how far are we from meeting prevention goals?
Associate Professor R. Gabulova (Baku, AZ)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePoster 3

The Event

Event poster

ESC Preventive Cardiology 2023

13 April - 15 April 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources